Serum metrix metalloproteinase-9 combined with homocysteine, IL-6, TNF-α, CRP, HbA11c and lipid profile in the incipient diabetic nephropathy with or without macrovascular diseases
Original articles_Clinical Medicine|Updated:2026-03-12
|
Serum metrix metalloproteinase-9 combined with homocysteine, IL-6, TNF-α, CRP, HbA11c and lipid profile in the incipient diabetic nephropathy with or without macrovascular diseases
Serum metrix metalloproteinase-9 combined with homocysteine, IL-6, TNF-α, CRP, HbA11c and lipid profile in the incipient diabetic nephropathy with or without macrovascular diseases
解放军医学杂志(英文版)2007年第2期 页码:111-114
Affiliations:
1. Department of Endocrinology Affiliated Hospital of North China Coal Medical College
2. Department of Endocrinology Affiliated Hospital of North China Coal Medical College Tangshan,063000
Author bio:
Funds:
DOI:
中图分类号:R587.2
纸质出版:2007
Accepted:
Scan QR Code
Serum metrix metalloproteinase-9 combined with homocysteine, IL-6, TNF-α, CRP, HbA11c and lipid profile in the incipient diabetic nephropathy with or without macrovascular diseases[J]. 解放军医学杂志(英文版), 2007,(2):111-114.
[1]贾伟,袁强,梁永平,王惠敏,韩向群,尹淑巧,朱晓梅,刘桂芝.Serum metrix metalloproteinase-9 combined with homocysteine, IL-6, TNF-α, CRP, HbA11c and lipid profile in the incipient diabetic nephropathy with or without macrovascular diseases[J].Journal of Medical Colleges of PLA,2007(02):111-114.
Serum metrix metalloproteinase-9 combined with homocysteine, IL-6, TNF-α, CRP, HbA11c and lipid profile in the incipient diabetic nephropathy with or without macrovascular diseases[J]. 解放军医学杂志(英文版), 2007,(2):111-114.DOI:
[1]贾伟,袁强,梁永平,王惠敏,韩向群,尹淑巧,朱晓梅,刘桂芝.Serum metrix metalloproteinase-9 combined with homocysteine, IL-6, TNF-α, CRP, HbA11c and lipid profile in the incipient diabetic nephropathy with or without macrovascular diseases[J].Journal of Medical Colleges of PLA,2007(02):111-114.DOI:
Serum metrix metalloproteinase-9 combined with homocysteine, IL-6, TNF-α, CRP, HbA11c and lipid profile in the incipient diabetic nephropathy with or without macrovascular diseases
摘要
Abstract
<正>Objective: To evaluate the changes of serum matrix metalloproteinase-9 (mmp-9) in patients of incipient diabetic nephropathy with or without macrovascular disease and to analyze the factors associated with homocysteine(hcy)
interleukin-6(IL-6)
tumor necrosis factor-alpha (TNF-α)
highly sensitive C-reactive protein (hsCRP)
HbA1c and lipid profile in those patients in order to know whether this marker or other factors are more important to induce diabetic macrovascular disease. Methods: Type 2 diabetes mellitus(T2DM) subjects with incipient diabetic nephropathy with or without macrovascular disease were selected for participation and divided into 2 groups. The patients in group 1(n= 38) used insulin
and patients in group 2 (n = 34) were treated with an oral antidiabetic drug. Then serum mmp-9
hcy
IL-6 and TNF-αin these patients were measured
and compared to the healthy subjects as control (n= 16). The results were analyzed by SPSS13. Results: Serum mmp-9 and hcy of the patients having incipient diabetic nephropathy with macrovascular disease were higher than that of patients without macrovascular disease (P<0. 01). For insulin-injected patients
whether they accompanied with macrovascular diseases or not
the serum levels of mmp-9
hcy
IL-6 and TNF-αwere all lower
but no significant statistics compared with non-insulin used patients or the healthy subjects. The serum level of mmp-9 was more correlated with the serum hcy in antidiabetic drug used patients. (P<0. 000) Conclusion: The serum level of mmp-9 plays an important role of pathogenesis in the macrovascular disease in the incipient diabetic patients
and the serum level of hcy also can reflect the severely degree of macrovascular disease in these patients
insulin can reduce these markers.
关键词
Keywords
references
The trial reading is over, you can activate your VIP account to continue reading.